Most adverse effects are associated with improper dosing and excessive intake
Clinical Psychology in Europe, 5, article e11699, (PDF) Rolle, C.E., Pedersen, M.L., Johnson, N., Amemori, K., Ironside, M., Graybiel, A., Pizzagalli, D.A., Etkin, A
Not FDA Approved Not available for routine prescribing or public use
Visceral Fat Level (VFL) : The highest-value metabolic outcome of GLP-1 therapy
By activating GLP-1 and GIP receptors, Retatrutide reduces appetite, increases insulin sensitivity, and enhances glucose metabolism
Semaglutide, the active ingredient in Ozempic and Wegovy, is labeled to a maximum of 2 mg weekly as Ozempic, while the 2.4 mg weekly dose belongs to Wegovy for weight managementthough most people find their personal optimal dose somewhere lower